-+ 0.00%
-+ 0.00%
-+ 0.00%

Vanda files Form 3 for Senior VP, Medical Director Christos Polymeropoulos

PUBT·04/13/2026 21:39:16
Listen to the news
Vanda files Form 3 for Senior VP, Medical Director Christos Polymeropoulos
  • Vanda Pharmaceuticals Senior VP, Medical Director Christos Vasilios Mihael Polymeropoulos reported 386,241 shares of common stock in an initial Form 3 filing dated April 1, 2026.
  • Filing also listed stock options covering 61,200 shares with an exercise price of $7.05.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vanda Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002128392-26-000003), on April 13, 2026, and is solely responsible for the information contained therein.